DPhil research opportunities 2023
The deadline for applications for any Oxford-administered scholarships, including the RDM Scholars Programme, has now passed. There are still some funded studentships and where funding is available the details and deadlines for application are provided in the individual project advert.
| Title | |
|---|---|
| Antanaviciute Group - Computational biology and machine learning for characterising spatial tissue niches and cellular signalling across space and time of human immune system development Antanaviciute Group - Computational biology and machine learning for characterising spatial tissue niches and cellular signalling across space and time of human immune system development | Agne Antanaviciute |
| Koohy Group - Applications of multi-omics and AI to better understand T cell immunity and antigen-specificity Koohy Group - Applications of multi-omics and AI to better understand T cell immunity and antigen-specificity | Hashem Koohy |
| Kini Group - A network approach to identifying novel genes causing neurodevelopmental disorders- The SATB pathway Kini Group - A network approach to identifying novel genes causing neurodevelopmental disorders- The SATB pathway | Usha Kini |
| Tyler Group - Development and Application of Novel Magnetic Resonance Imaging Approaches for the Assessment of Multi-System Disease (Funding available) Tyler Group - Development and Application of Novel Magnetic Resonance Imaging Approaches for the Assessment of Multi-System Disease (Funding available) | Damian Tyler |
| Chakraverty Group - Design of advanced haematopoietic stem cell and T cell therapies (Funding available) Chakraverty Group - Design of advanced haematopoietic stem cell and T cell therapies (Funding available) | Ronjon Chakraverty |
| Antoniades Group - Cross-talk between adipose tissue and the cardiovascular system in humans: From novel imaging biomarkers development to drug target discovery Antoniades Group - Cross-talk between adipose tissue and the cardiovascular system in humans: From novel imaging biomarkers development to drug target discovery | Charalambos Antoniades |
| Douglas Group - Functional coronary artery disease genetics - defining the function of new causal atherosclerosis genes from CAD GWAS loci using in vitro and in vivo models Douglas Group - Functional coronary artery disease genetics - defining the function of new causal atherosclerosis genes from CAD GWAS loci using in vitro and in vivo models | Gillian Douglas |
| Karpe Group - Human fat distribution and metabolic disease Karpe Group - Human fat distribution and metabolic disease | Fredrik Karpe |
| Leeson Group - Imaging in Preventive Cardiology Research Leeson Group - Imaging in Preventive Cardiology Research | Paul Leeson |
| Lygate Group - Realising the therapeutic potential of creatine and homoarginine in heart disease Lygate Group - Realising the therapeutic potential of creatine and homoarginine in heart disease | Craig Lygate |
| Piechnik Group - Myocardial functional T1 mapping – Advanced cardiac magnetic resonance imaging techniques Piechnik Group - Myocardial functional T1 mapping – Advanced cardiac magnetic resonance imaging techniques | Stefan Piechnik |
| Reilly Group - Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation Reilly Group - Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation | Svetlana Reilly |
| Tzima Group - Go with the flow---the why and how of cardiovascular disease Tzima Group - Go with the flow---the why and how of cardiovascular disease | Ellie Tzima |
| Watkins Group – Creating genetic therapies for inherited heart muscle disease Watkins Group – Creating genetic therapies for inherited heart muscle disease | Hugh Watkins |
| Drakesmith Group - Iron Biology Drakesmith Group - Iron Biology | Hal Drakesmith |
| Goriely Group - De Novo Mutations and Human Disease Goriely Group - De Novo Mutations and Human Disease | Anne Goriely |
| Higgs Group - Laboratory of Gene Regulation Higgs Group - Laboratory of Gene Regulation | Douglas Higgs |
| Mead Group - Unravelling intratumoural heterogeneity in Myeloproliferative Neoplasms Mead Group - Unravelling intratumoural heterogeneity in Myeloproliferative Neoplasms | Adam Mead |
| Twigg/Wilkie Group - Building the skull – normal and abnormal development Twigg/Wilkie Group - Building the skull – normal and abnormal development | Stephen Twigg |
| Nerlov Group - Hematopoietic Stem Cell Genetics Nerlov Group - Hematopoietic Stem Cell Genetics | Claus Nerlov |
| Patel Group - Origins of Genotoxic metabolism and the DNA damage response in stem and cancer cells Patel Group - Origins of Genotoxic metabolism and the DNA damage response in stem and cancer cells | KJ Patel |
| Toepfer Group - Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9. Toepfer Group - Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9. | Christopher Toepfer |
| Chapman Group - Homologous recombination in genome maintenance and cancer prevention (Funding available) Chapman Group - Homologous recombination in genome maintenance and cancer prevention (Funding available) | Ross Chapman |
| Christodoulides Group– Deciphering the role of white and brown adipocytes in metabolic disease. Christodoulides Group– Deciphering the role of white and brown adipocytes in metabolic disease. | Constantinos Christodoulides |
| Davis Group - Therapeutic opportunities emerging from studies of immune checkpoints Davis Group - Therapeutic opportunities emerging from studies of immune checkpoints | Simon Davis |
| David Hodson Group - Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues David Hodson Group - Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues | David Hodson |
| Valkovič Group - Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy Valkovič Group - Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy | Ladislav Valkovic |
| Akbar Group - Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential. Akbar Group - Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential. | Naveed Akbar |